These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 19844797

  • 1. Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
    Johnsen NF, Olsen A, Thomsen BL, Christensen J, Egeberg R, Bach Knudsen KE, Loft S, Overvad K, Tjønneland A.
    Cancer Causes Control; 2010 Jan; 21(1):153-62. PubMed ID: 19844797
    [Abstract] [Full Text] [Related]

  • 2. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
    Aarestrup J, Kyrø C, Knudsen KE, Weiderpass E, Christensen J, Kristensen M, Würtz AM, Johnsen NF, Overvad K, Tjønneland A, Olsen A.
    Br J Nutr; 2013 Jun 28; 109(12):2269-75. PubMed ID: 23114205
    [Abstract] [Full Text] [Related]

  • 3. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Møller S, Tjønneland A.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 28; 13(12):2084-9. PubMed ID: 15598765
    [Abstract] [Full Text] [Related]

  • 4. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
    Kyrø C, Frederiksen K, Holm M, Nørskov NP, Knudsen KEB, Overvad K, Tjønneland A, Olsen A.
    Br J Nutr; 2019 Sep 14; 122(5):552-563. PubMed ID: 30173678
    [Abstract] [Full Text] [Related]

  • 5. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
    Kyrø C, Hansen L, Frederiksen K, Nørskov NP, Bach Knudsen KE, Eriksen AK, Holm M, Tjønneland A, Olsen A.
    Clin Nutr; 2018 Dec 14; 37(6 Pt A):2217-2225. PubMed ID: 29154112
    [Abstract] [Full Text] [Related]

  • 6. Use of antibiotics is associated with lower enterolactone plasma concentration.
    Bolvig AK, Kyrø C, Nørskov NP, Eriksen AK, Christensen J, Tjønneland A, Knudsen KE, Olsen A.
    Mol Nutr Food Res; 2016 Dec 14; 60(12):2712-2721. PubMed ID: 27500753
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
    Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H.
    Cancer Causes Control; 2004 Dec 14; 15(10):1095-102. PubMed ID: 15801493
    [Abstract] [Full Text] [Related]

  • 8. Serum enterolactone concentrations are low in colon but not in rectal cancer patients.
    Tuomisto A, Nørskov NP, Sirniö P, Väyrynen JP, Mutt SJ, Klintrup K, Mäkelä J, Bach Knudsen KE, Mäkinen MJ, Herzig KH.
    Sci Rep; 2019 Aug 01; 9(1):11209. PubMed ID: 31371751
    [Abstract] [Full Text] [Related]

  • 9. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
    Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Grönberg H, Bälter KA.
    Cancer Causes Control; 2006 Mar 01; 17(2):169-80. PubMed ID: 16425095
    [Abstract] [Full Text] [Related]

  • 10. Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort.
    Eriksen AK, Kyrø C, Nørskov NP, Frederiksen K, Bach Knudsen KE, Overvad K, Landberg R, Tjønneland A, Olsen A.
    Diabetologia; 2019 Jun 01; 62(6):959-969. PubMed ID: 30963187
    [Abstract] [Full Text] [Related]

  • 11. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
    Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr 01; 10(4):339-44. PubMed ID: 11319174
    [Abstract] [Full Text] [Related]

  • 12. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.
    Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT.
    Lancet; 2001 Apr 01; 354(9196):2112-5. PubMed ID: 10609816
    [Abstract] [Full Text] [Related]

  • 13. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
    Guglielmini P, Rubagotti A, Boccardo F.
    Breast Cancer Res Treat; 2012 Apr 01; 132(2):661-8. PubMed ID: 22094938
    [Abstract] [Full Text] [Related]

  • 14. Variation in fasting and non-fasting serum enterolactone concentrations in women of the Malmö Diet and Cancer cohort.
    Sonestedt E, Ericson U, Gullberg B, Peñalvo JL, Adlercreutz H, Wirfält E.
    Eur J Clin Nutr; 2008 Aug 01; 62(8):1005-9. PubMed ID: 17538540
    [Abstract] [Full Text] [Related]

  • 15. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R, Chang-Claude J, Linseisen J.
    Eur J Cancer Prev; 2006 Jun 01; 15(3):225-32. PubMed ID: 16679865
    [Abstract] [Full Text] [Related]

  • 16. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
    Olsen A, Christensen J, Knudsen KE, Johnsen NF, Overvad K, Tjønneland A.
    Breast Cancer Res Treat; 2011 Aug 01; 128(3):883-9. PubMed ID: 21340481
    [Abstract] [Full Text] [Related]

  • 17. An incident case-referent study on plasma enterolactone and breast cancer risk.
    Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G.
    Eur J Nutr; 2002 Aug 01; 41(4):168-76. PubMed ID: 12242585
    [Abstract] [Full Text] [Related]

  • 18. Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.
    Wallström P, Drake I, Sonestedt E, Gullberg B, Bjartell A, Olsson H, Adlercreutz H, Tikkanen MJ, Wirfält E.
    Eur J Nutr; 2018 Oct 01; 57(7):2595-2606. PubMed ID: 28884432
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
    Stuedal A, Gram IT, Bremnes Y, Adlercreutz H, Veierød MB, Ursin G.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 01; 14(9):2154-9. PubMed ID: 16172225
    [Abstract] [Full Text] [Related]

  • 20. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, Kaaks R, Linseisen J, Obi N, Heinz J, Flesch-Janys D, Chang-Claude J.
    Int J Cancer; 2014 Aug 15; 135(4):923-33. PubMed ID: 24436155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.